CJC-1295 No DAC (5mg) | Ipamorelin (5mg) Blend

Product Specifications & Scientific Profile

This formulation represents a high-purity synergistic blend designed for advanced laboratory evaluation. It comprises equal concentrations of two potent growth hormone secretagogues:

• CJC-1295 (No DAC) [5mg]: A synthetic analog of Growth Hormone-Releasing Hormone (GHRH). It functions by binding to the GHRH receptor, thereby facilitating the pulsatile release of endogenous growth hormone.

• Ipamorelin [5mg]: A pentapeptide classified as a highly selective agonist of the ghrelin/growth hormone secretagogue receptor. It is distinguished in research for its ability to stimulate GH secretion without significantly impacting prolactin or cortisol levels.

• Synergistic Potentiation: Scientific observation suggests that the concurrent administration of a GHRH analog and a ghrelin mimetic results in a synergistic effect, yielding a significantly higher GH response than either compound used in isolation.

Regulatory Compliance & Mandatory Disclaimer

Strict Research Designation: This product is intended for RESEARCH PURPOSES ONLY. It is not intended for human or animal consumption, nor is it to be used for diagnostic or therapeutic purposes.

• Prohibited Use: Any form of in vivo administration into humans or animals is strictly prohibited by law.

• Handling Requirements: This substance is a research chemical and must be handled exclusively by licensed, qualified professionals within a controlled laboratory environment.

• Classification: This product is not classified as a drug, food, or cosmetic. It may not be misbranded, misused, or mislabeled as a medical or consumer commodity.

• Educational Context: All data and information provided are for educational and academic purposes only, relating specifically to in vitro laboratory experimentation.